Victor Levitsky

Victor Levitsky

Company: Targovax

Job title: Chief Scientific Officer


Modulation Of The Tumor Micro-Environment By Oncos-102 – Experience From Several Types Of Cancer 9:00 am

• ONCOS-102 acts synergistically to reduce tumor volume with the chemotherapy combination of pemetrexed and cisplatin (Pem/Cis), which is the current standard of care in malignant pleural mesothelioma • Demonstration that ONCOS-102 induces CD8+ T-cells specific to the tumor associated antigen (TAA) mesothelin, which is typically overexpressed in mesothelioma, as well as many other forms…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.